[1] |
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
|
[2] |
Wang R, Chinnaiyan AM, Dunn RL, et al. Rational approach to implementation of prostate cancer antigen 3 into clinical care[J]. Cancer, 2009, 115(17): 3879-3886.
|
[3] |
Sciarra A, Barentsz J, Bjartell A, et al. Advances in magnetic resonance imaging: how they are changing the management ofprostate cancer[J]. Eur Urol, 2011, 59(6): 962-977.
|
[4] |
Sciarra A, Panebianco V, Ciccariello M, et al. Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy[J]. Clin Cancer Res, 2010, 16(6): 1875-1883.
|
[5] |
Sciarra A, Panebianco V, Cattarino S, et al. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy[J]. BJU Int, 2012, 110(11): 1661-1665.
|
[6] |
Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS prostate imaging-reporting and data system: 2015, Version 2[J]. Eur Urol, 2016, 69(1): 16-40.
|
[7] |
Luo Y, Gou X, Huang P, Mou C. The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis[J]. Asian J Androl, 2014, 16(3): 487-92.
|
[8] |
Cui Y, Cao W, Li Q, et al. Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis[J]. Sci Rep, 2016, 6: 25776.
|
[9] |
Lawrentschuk N, Fleshner N. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate specific antigen levels[J]. BJU Int, 2009, 104(6): 730-733.
|
[10] |
Haffner J, Lemaitre L, Puech P, et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection[J]. BJU Int, 2011, 108 (8 Pt 2): E171-E178.
|
[11] |
张其强, 赵云丽, 张学宝, 等. PCA3基因在前列腺癌的诊断和治疗中的研究进展[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(03): 207-210.
URL
|
[12] |
Yousaf T, Dervenoulas G, Politis M. Advances in MRI methodology[J]. Int Rev Neurobiol, 2018, 141: 31-76.
|